AI technology developer Blackford will make several Coreline Soft AVIEW products for thoracic CT available through the Blackford platform.
Blackford will offer AVIEW LCS for identifying and assessing pulmonary nodules in lung cancer screening; AVIEW COPD for low attenuation area and high attenuation area analysis in chronic obstructive pulmonary disease (COPD); and AVIEW CAC, which scores coronary artery calcium deposits for risk stratification. All three are available in a bundle called AVIEW LCS Plus, according to Blackford.
AVIEW Lung Texture will also be available for evaluating interstitial lung diseases once it has been cleared by the U.S. Food and Drug Administration (FDA), Blackford noted.
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
